x

Coronavirus

CureVac Drops COVID-19 Vaccine, Pins Hope on Next-Generation Shots

October 13, 2021

LONDON — The German biotechnology company CureVac says it has withdrawn its application for the approval of its coronavirus vaccine from the European Medicines Agency and will focus on making next-generation messenger RNA vaccines.

In a statement on Tuesday, CureVac says recent communications with the EU drug regulator suggested its COVID-19 vaccine might only be authorized in mid-2022. Earlier this year, the company described its initial vaccine results as “sobering,” after data suggested the shot was only about 47% effective.

CureVac says it will instead prioritize the development of second-generation mRNA vaccines with its partner GlaxoSmithKline and expects to be in “late-stage clinical development” by the middle of next year.

The EMA confirmed Tuesday it had ended the accelerated evaluation of the CureVac vaccine, a process started in February. COVAX, the U.N.-backed effort to share vaccines globally, had been waiting for possible doses from CureVac, which received funding from one of the COVAX partners.

RELATED

ATHENS – While the New Democracy government is easing health restrictions for rabid anti-vaxxers, those fully vaccinated against COVID-19 may need a fourth shot in the autumn.

Top Stories

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

General News

PHILADELPHIA – The Federation of Hellenic Societies of Philadelphia and Greater Delaware Valley announced that the Evzones, the Presidential Guard of Greece will be participating in the Philadelphia Greek Independence Day Parade on March 20.

Video

TNΗ’s Happenings of the Week by Eraklis Diamataris

NEW YORK – The National Herald’s Happenings of the Week as have been reported at the print and digital editions of TNH and presented by the TNH Editor Eraklis Diamataris.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. abc@xyz.com

You may unsubscribe at any time using the link in our newsletter.